4,000 patients join Long-Term ILD observation study

NCT ID NCT00470327

First seen Jun 12, 2026 · Last updated Jun 12, 2026

Summary

This study follows up to 4,000 people with interstitial lung disease (ILD) to understand how the condition naturally progresses. Researchers will collect medical data and blood samples from participants, as well as from a control group without ILD, to describe the disease's patterns. The goal is to learn more about ILD, not to test a new treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IDIOPATHIC PULMONARY FIBROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-••••

Locations

  • University of Chicago

    RECRUITING

    Chicago, Illinois, 60637, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

The condition(s) this trial relates to.

Connective Tissue Diseases Idiopathic Pulmonary Fibrosis Lung Diseases, Interstitial Sarcoidosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.